“MIRON-TROP Clinical Trial in “New England Journal of Medicine - Evidence”
https://t.co/FLkG6cdns2
First Ever: Troponin is no longer just a marker of any MI — Post-PCI Troponin is a precision diagnostic method to identify Hemorrhagic MI.
@rohandkumar1@IUMedSchool@IURadiology
It was an excellent clinical conference at the SCMR 29th Annual Scientific Sessions at Rio de Janeiro, Brazil to present our latest trials showcasing the critical role of Cardiovascular MRI in STEMI care. @IURadiology@IUMedSchool@IU_Health@rohandkumar1@SCMR@BrunoLimaMDPhD
MIRON-TROP trial at #TCT2025 San Francisco
Our research identifies a key driver of in-hospital mortality post-PCI: hemorrhagic myocardial infarction.
We found that post-procedural troponin kinetics can be used to diagnose this critical stage of MI
Thank you @CRFheart & @TCTMD
Hemorrhagic MI is why STEMI needs a pre-PCI checkpoint. Treat speed + wisdom: before PCI, hold the cine, watch collaterals, record Rentrop. A small pause that upgrades CCU triage, imaging, and follow-up.
Rentrop in every Cath report of MI.
MIRON-CL Trial
https://t.co/GbPr4ZagbY
A simple blood test developed by the IU School of Medicine is helping identify heart attack patients at a high risk for complications. https://t.co/1gSiqlchND
Intramyocardial hemorrhage following primary PCI is a major predictor of adverse cardiovascular outcomes but is difficult to diagnose in real time. Vora et al. describe the use of post-PCI troponin kinetics to make the diagnosis. https://t.co/JMaXgmRkvb
“Not all MIs are the same”
- First Blood Test Diagnostic of Hemorrhagic MI
- First Clinical Trial of Post-PCI High Sensitvity Troponin Kinetics Study
- First acute biomarker to stratify post-PCI patients in CCU@rohandkumar1 @inacc https://t.co/sJVvwueSLS
Live-Attenuated Intranasal RSV Vaccine in Infants and Toddlers https://t.co/1EtKFS7UiV
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma https://t.co/zuxJTV7LI8
In-Hospital Mortality in Hemorrhagic Myocardial Infarction https://t.co/JMaXgmQMFD
I’ll be attending the amazing Indiana-ACC Annual Meeting 2025 on September 13, 2025 at Marriott Indianapolis North. Let me know if you’re planning to attend so that we can say Hi! 👋
Or register now and join me at the event!
https://t.co/7ZenfoaKY2
Honored to present at #ACCAsia on:
In-hospital Mortality in Hemorrhagic Myocardial Infarction: Diagnostics to Implications
Thank you @ACCinTouch & @SingCardiacSoc for the opportunity to share this work.
Proud to represent @IURadiology & SCVRI India !!!
In this #JACCAdvances state-of-the-art review, Dr. Dharmakumar, et al explore advancements & challenges in #cvAMI management. They review 🔑 insights from the prereperfusion era & summarize observations in reperfusion therapy.
Get the details: https://t.co/7DISvDYrEi #cvMI
"Our State-of-the-Art Review traces the history of Myocardial Infarction. Despite decades of reperfusion advances, intramyocardial hemorrhage remains the missing key in post-MI care." @IUMedSchool@IUHealthFdn
https://t.co/VpiQrWXbfM
@Interve15538505@POCUSEcho@echotalk@echocardiac@GKardiyolog Right Atrial Thrombus Secondary to Endothelial Damage Post-HD Catheter Removal with Coexisting Chiari Network Remnant at the IVC-RA Junction.
It would be interesting to know PFO status as chiari mostly co-exists with PFO. Share bubble study if you do. Thanks